Stryker Corporation (BVMF:S1YK34)
Brazil flag Brazil · Delayed Price · Currency is BRL
92.52
+0.10 (0.11%)
At close: Jan 29, 2026

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Instruments Revenue
3.18B2.83B
Instruments Revenue Growth
12.31%11.84%
Endoscopy Revenue
3.81B3.39B
Endoscopy Revenue Growth
12.33%10.46%
Medical Revenue
4.20B3.85B
Medical Revenue Growth
9.14%11.36%
Neurovascular Revenue
1.97B1.31B
Neurovascular Revenue Growth
50.57%6.61%
Neuro Cranial Revenue
2.49B2.14B
Neuro Cranial Revenue Growth
16.34%13.86%
MedSurg & Neurotechnology Revenue
15.65B13.52B
MedSurg & Neurotechnology Revenue Growth
15.75%11.14%
Knees Revenue
2.66B2.45B
Knees Revenue Growth
8.54%7.66%
Hips Revenue
1.87B1.70B
Hips Revenue Growth
9.45%10.36%
Trauma and Extremities Revenue
3.95B3.51B
Trauma and Extremities Revenue Growth
12.57%11.44%
Spinal Implants Revenue
185.00M707.00M
Spinal Implants Revenue Growth
-73.83%-0.84%
Other Orthopaedics Revenue
815.00M712.00M
Other Orthopaedics Revenue Growth
14.47%8.21%
Orthopaedics Revenue
9.47B9.08B
Orthopaedics Revenue Growth
4.32%8.90%
Revenue (Total)
25.12B22.60B
Revenue (Total) Growth
11.16%10.23%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
19.01B16.94B
United States Revenue Growth
12.18%11.05%
International Revenue
6.11B5.65B
International Revenue Growth
8.10%7.84%
Revenue (Total)
25.12B22.60B
Revenue (Total) Growth
11.16%10.23%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg & Neurotechnology Operating Income
-4.00B
MedSurg & Neurotechnology Operating Income Growth
-15.39%
Orthopaedics Operating Income
-2.59B
Orthopaedics Operating Income Growth
-14.39%
Operating Income (Total)
4.89B3.69B
Operating Income (Total) Growth
32.53%-5.12%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Organic Net Sales Growth
10.30%10.20%
Updated Dec 31, 2025. Data Source: Fiscal.ai.